MWR
PPH icon

McAdams Wright Ragen’s VanEck Pharmaceutical ETF PPH Stock Holding History

McAdams Wright Ragen’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.22M Sell
19,230
-30
-0.2% -$1.86K 0.07% 180
2014
Q2 		$1.19M Hold
19,260
– – 0.07% 177
2014
Q1 		$1.12M Sell
19,260
-100
-0.5% -$5.66K 0.07% 174
2013
Q4 		$1.03M Sell
19,360
-1,910
-9% -$96.7K 0.07% 180
2013
Q3 		$1.02M Sell
21,270
-75
-0.4% -$3.56K 0.08% 162
2013
Q2 		$971K Buy
+21,345
New +$987K 0.08% 174

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

McAdams Wright Ragen's PPH Position: Q3 2014 in Review

McAdams Wright Ragen reduced its VanEck Pharmaceutical ETF (PPH) stake by 0.16% in Q3 2014, selling an estimated $1.86K and leaving 19,230 shares worth $1.22M. The position accounts for 0.07% of the portfolio, ranked #180.

McAdams Wright Ragen first reported a position in PPH in Q2 2013 and has held it in 6 quarters since. 49 funds tracked by Wall St. Rank hold PPH as of Q3 2014.

  • McAdams Wright Ragen held 19,230 shares of VanEck Pharmaceutical ETF worth $1.22M as of Q3 2014.
  • McAdams Wright Ragen sold 30 VanEck Pharmaceutical ETF shares in Q3 2014, an estimated $1.86K.
  • VanEck Pharmaceutical ETF made up 0.07% of McAdams Wright Ragen's portfolio in Q3 2014, its #180 holding.
  • McAdams Wright Ragen first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 6 quarters since.
  • 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.